Publikationen

Corresponding author is indicated with *

Updated publication list and citation statistics:

google scholar profile of A. Mokhir

2024

  1. Arkhypov, A.; Klemt, I.; Bila, G.; Bilyy, R.; Mokhir, A. Targeting lysosomal thiols for immunogenic cancer cell death. Angew. Chem. Int. Ed. 2024, https://doi.org/10.1002/anie.202417509.
  2. Chernii, S.; Selin, R.; Bila, G.; Bilyy, R.; Körber, M.; Mokhir, A.* Red fluorescent aminoferrocene (pro)drugs for in cellulo and in vivo imaging. Chem. Eur. J. 2024, accepted, http://dx.doi.org/10.1002/chem.202401107.
  3. Klemt, I.; Reshetnikov, V.; Dutta, S.; Bila, G.; Bilyy, R.; Cossío Cuartero, I.;  Hidalgo, A.; Wünsche, A.; Böhm, M.; Wondrak, M.; Kunz-Schughart, L.; Tietze, R.; Beierlein, F.; Imhof, P.; Gensberger-Reigl, S.; Pischetsrieder, M.; Körber, M.; Jost, T.; Mokhir, A.* A prodrug activated by H2O2 and mitochondrial hydroxide: an improvement of cancer cells versus neutrophils selectivity. RSC. Med. Chem. 2024, https://doi.org/10.1039/D3MD00609C.
  4. Beierlein, F.; Horn, A. H. C.; Sticht, H.; Mokhir, A.; Imhof, P.* In silico study of camptothecin-based pro-drugs binding to human carboxyl esterase 2. Biomolecules 2024, 14(2), 153. https://doi.org/10.3390/biom14020153.
  5. Schuster, F.; Grau, B. W.; Xu, H.-G.; Mokhir, A.; Tsogoeva, S. B.* Dipeptide-catalysed Michael reaction under physiological conditions: examination of potential bioorthogonality. Bioorg. Med. Chem. 2024, 2(22), 117650. https://doi.org/10.1016/j.bmc.2024.117650.

2023

  1. Klemt, I.; Varzatskii, O.; Selin, R.; Vakarov, S.; Kovalska, V.; Bila, G.; Bilyy, R.; Voloshin, Y.; Cuartero, I. C.; Hidalgo, A.; Frey, B.; Becker, I.; Friedrich, B.; Tietze, R.; Friedrich, R. P.; Alexiou, C.; Ursu, E.-L.; Rotaru, A.; Solymosi, I.; Pérez-Ojeda, M. E. and Mokhir, A.* 3D-shaped binders of unfolded proteins inducing cancer cell specific endoplasmic reticulum stress in vitro and in vivo. J. Am. Chem. Soc., 2023, 145(40), 22252-22264. https://pubs.acs.org/doi/10.1021/jacs.3c08827.
  2. Rühle, J.; Klemt, I.; Mokhir, A.* Triggering RNA interference by photoreduction under red light irradiation. Molecules, 2023, 28(10), 4204. https://doi.org/10.3390/molecules28104204.
  3. Köckenberger, J.; Klemt, I.; Sauer, C.; Arkhypov, A.; Reshetnikov, V.; Mokhir, A.*; Heinrich, M. R.* Cyanine- and rhodamine-derived alkynes for the selective targeting of cancerous mitochondria via radical thiol-yne coupling in live cells. Chemistry, Eur. J., 2023, e202301340. https://doi.org/10.1002/chem.202301340.
  4. Morozov, B. S.; Oshchepkov, A. S.; Klemt, I.; Agafontsev, A. M.; Krishna, S.; Hampel, F.; Xu, H.-G.; Mokhir, A.; Guldi, D.;* Kataev, E.* Supramolecular recognition of cytidine phosphate in nucleotides and RNA sequences. J. Am. Chem. Soc. Au, 2023, 3, 3, 964-977. https://pubs.acs.org/doi/full/10.1021/jacsau.2c00658.

2022

  1. Rühle, J.; Klemt, I.; Abakumova, T.; Sergeeva, O.; Vetosheva, P.; Zatsepin, T.;* Mokhir, A.* Reactive oxygen species – responsive RNA interference. Chem. Comm, 2022, 58, 4388-4391.
  2. Özkan, H. G.; Thakor, V.; Xu, H.; Bila, G; Bilyy, R.; Bida, D.; Böttcher, M.; Mougiakakos, D.; Tietze, R.; Mokhir, A.* Anticancer aminoferrocene derivatives inducing production of mitochondrial reactive oxygen species. Chem. Eur. J., 2022, e202104420, https://doi.org/10.1002/chem.202104420.
  3. Xu, H.; Reshetnikov, V.; Wondrak, M.; Eckhardt, L.; Kunz-Schughart, L. A.; Janko, C.; Tietze, R.; Alexiou, C.; Borchardt, H.; Aigner, A.; Gong, W.; Schmitt, M.; Sellner, L.; Daum, S.; Özkan, H. G.; Mokhir, A.* Intracellular amplifiers of reactive oxygen species affecting mitochondria as radiosensitizers. Cancers, 2022, 14(1), 208 (by invitation, special issue: The Emerging Hallmarks of Cancer Metabolism for Precision Oncology Applications).
  4. Özkan, H. G.; Mokhir, A.* A prodrug of 3-(ferrocenylaminocarbonyloxymethyl)phenol activated by reactive oxygen species in cancer cells. J. Inorg. Biochem., 2022, published online: https://doi.org/10.1016/j.jinorgbio.2022.111859.
  5. Xu, H.; Annamadov, S.; Mokhir, A.* 4-Ferrocenylaniline-based ROS-responsive prodrugs with anticancer activity. J. Organometallic Chem., 2022, 964, 122305 (by invitation, special issue: International Symposium on Bioorganometallic Chemistry 2021).
  6. Aristova, D.; Selin, R.; Heil, H. S.; Kosach, V.; Slominsky, Y.; Yarmoluk, S.; Pekhnyo, V.; Kovalska, V.; Henriques, R.; Mokhir, A.; Chernii, S. Trimethine Cyanine Dyes as NA-sensitive probes for visualization of cell compartments in fluorescence microscopy. ACS Omega, 2022, 7(51), 47734-47746.
  7. Stein, R.;* F. Pfister, Blersch, P.-R.;Unterweger, H.; Arkhypov, A.; Mokhir, A.; Kolot, M.; Alexiou, C.; Tietze, R.* Plasmid-DNA delivery by covalently functionalized PEI-SPIONs as a potential ‚magnetofection‘ agent. Molecules, 2022, published online: https://doi.org/10.3390/molecules27217416.

2021

  1. Xu, H.; Schikora, M.; Sisa, M.; Daum, S.; Klemt, I.; Janko, C.; Alexiou, C.; Bila, G.; Bilyy, R.; Gong, W.; Schmitt, M.; Sellner, L.; Mokhir, A.* An endoplasmic reticulum – specific pro-amplifier of reactive oxygen species in cancer cells. Angew. Chem. Int. Ed. , 2021, 60(20), 11158-11162.
  2. Özkan, H. G.; Toms, J.; Maschauer, S.; Prante, O.; Mokhir, A.* Aminoferrocene-based anticancer prodrug labelled with cyanine dyes for in vivo imaging. Eur. J. Inorg. Chem., 2021, 48, 5096-5102 (by invitation, special collection: Ferrocene Chemistry).
  3. Aristova, D.; Kosach, V.; Chernii, S.; Slominsky, Y.; Balanda, A.; Filonenko, V.; Yarmoluk, S.; Rotaru, A.; Özkan, H. G.; Mokhir, A.*; Kovalska, V. Monomethine cyanine probes for visualization of cellular RNA by fluorescence microscopy. Methods Appl. Fluoresc., 2021, 9, 045002.
  4. Shylin, S. I.; Pogrebetsky, J. L.; Husak, A. O.; Bykov, D.; Mokhir, A.; Hampel, F.; Shova, S.; Ozarowski, A.; Gumienna-Kontecka, E.; Fritsky, I. O.* Expanding manganese(IV) aqueous chemistry: unusually stable water-soluble hexahydrazide clathrochelate complexes. Chem. Comm., 2021, 57, 11060-11063.
  5. Roviello, V.; Musumeci, D.; Mokhir, A.; Roviello, G. N.* Evidence of protein binding by a nucleopeptide based on a thymine-decorated L-diaminopropanoic acid through CD and in silico studies. Curr. Med. Chem., 2021, 28.
  6. Syniugina, A.;* Chernii, S.; Losytskyy, M.; Syniugin, A.; Slominskii, Yu.; Balanda, A.; Özkan, H. G.; Mokhir, A.; Kovalska, V.; Yarmoluk, S. The synthesis and study of novel merocyanine probes for protein detection and cells visualization. J. Photochem. Photobiol., 2021, 100046.
  7. Selin, R. O.; Klemt, I.; Chernii, V. Ya.*; Losytskyy, M. Yu.; Chernii, S.; Mular, A.; Gumienna-Kontecka, E.; Kovalska, V. B.; Voloshin, Y. Z.; Vologzhanina, A. V.; Dorovatovskii, P. V.; Mokhir, A. Synthesis and spectral characterization of the first fluorescein-tagged iron(II) chlathochelates, their supramolecular interactions with globular proteins, and cellular uptake. RSC Adv., 2021, 11(14), 8163-8177.

2020

  1. Dutta, S.; Rühle, J.; Schikora, M.; Deussner-Helfmann, N.; Heilemann, M.; Zatsepin, T.; Duchstein, P.; Zahn, D.; Knör, G.; Mokhir, A.* Red light-triggered photoreduction on a nucleic acid template. Chem. Comm., 2020, 56, 10026-10029.
  2. Zeh, G.; Haines, P.; Miehlich, M. E.; Kienz, T.; Neidlinger, A.; Friedrich, R. P.; Özkan, H. G.; Alexiou, C.; Hampel, F.; Guldi, D. M.; Meyer, K.; Schatz, J.; Heinze, K.; Mokhir, A.* Anticancer effects of an electronically coupled oligoferrocene. Organometallics, 2020, 39(17), 3112-3120.
  3. Reshetnikov, V.; Özkan, H. G.; Daum, S.; Janko, C.; Alexiou, C.; Sauer, C.; Heinrich, M. R.; Mokhir, A.* N-Alkylaminoferrocene-based prodrugs targeting mitochondria of cancer cells. Molecules, 2020, 25(11), 2545.
  4. Aristova, D.; Volynets, G.; Chernii, S.; Losytskyy, M.; Balanda, A.; Slominski, Yu.; Mokhir, A.; Yarmoluk, S.; Kovalska, V.* Far-red pentamethine cyanine dyes as fluorescent probes for detection of serum albumins. R. Soc. Open Sci., 2020, 7(7), 200453.
  5. Musumeci, D.; Mokhir, A.; Roviello, G. N.* Synthesis and nucleic acid binding evaluation of a thyminyl L-diaminobutanoic acid-based nucleopeptide. Bioorg. Chem., 2020, 103862.
  6. Snihirova, Y.V.; Losytskyy, M. Yu.; Kryvorotenko, D.V.; Kuperman, M.V.; Moshynets, O.V.; Yarmoluk, S.M.; Mokhir, A.; Kovalska, V.B.* Variation of photostability of DNA-sensitive styrylcyanine dyes caused by N-alkyl functionalization. Biopolymers & Cell, 2020, 36(2), 146-160.
  7. Selin, R.*; Chernii, V.; Mokhir, A. Synthesis of modified fluorescein for click reactions. Ukr. Chem. J., 2020, 86(3), 3-8.

2019

  1. Chercheja, S.; Daum, S.; Xu, H.; Beierlein, F.; Mokhir, A.* Hybrids of a 9-Anthracenyl Moiety and Fluorescein as Chemodosimeters for Detection of Singlet Oxygen in Live Cells. Org. Biomol. Chem., 2019, 17(46), 9883-9891.
  2. Zozulia, O.; Bachmann, T.; Deussner-Helfmann, N.; Beierlein, F.; Heilemann, M.; Mokhir, A.* Red Light-Triggered Nucleic Acid-Templated Reaction Based on Cyclic Oligonucleotide Substrates. Chemical Communications, 2019, 55(72), 10713-10716.
  3. Daum, S.; Toms, J.; Reshetnikov, V.; Özkan, H. G.; Hampel, F.; Maschauer, S.;  Hakimioun, A.; Beierlein, F; Sellner, L.; Schmitt, M.; Prante, O.;* Mokhir, A.* Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with 18F. Bioconjugate Chem., 2019, 30(4), 1077-1086.
  4. Zozulia, O.; Bachmann, T.; Mokhir, A.* Red Light Triggered Fluorogenic Reaction with Picomolar Sensitivity Towards Nucleic Acids. Bioconjugate Chem., 2019, 30(7), 2023-2031.
  5. Hahn, J.; Euler, M.; Kilgus, E.; Kienhöfer, D.; Stoof, J.; Knopf, J.; Hahn, M.; Harrer, T.; Hultqvist, M.; Olofsson, P.; Mokhir, A.; Holmdahl, R.; Herrmann, M.; Schett, G.; Muñoz, L. E.; Hoffmann, M. H.* NOX2 Mediates Qiuescent Handling of Dead Cell Remnants in Phagocytes. Redox Biol., 2019, 26, 101279.
  6. Kovalska, V.;* Vakarov, S.; Losytskyy, M.; Kuperman, M.; Chornenka, N.; Toporivska, Y.; Gumienna-Kontecka, E.; Voloshin, Y.; Varzatskii, O.; Mokhir, A. Dicarboxyl-Terminated Iron(II) Clathrochelates as ICD-Reporters for Globular Proteins. ACS Advances, 2019, 9(42), 24218-24230.
  7. Selin, R. A.; Chornenka, N. V.; Chernii, V. Ya.; Mokhir, A.; Vologzhanina, A. V.; Belov, A. S.; Pomadchik, A. L.; Voloshin, Y. Z.* Chemical Design of Heterodifunctionalized Iron(II) Clathrochelates with Terminal Biorelevant Carboxyl Group and Reactive Tripple C=C bond: Synthesis, Structure, Redox Properties and Their Stability in Various Media. Inorg. Chim. Acta, 2019, 496, 119047.
  8. Yoo, H. Y; Liu, Y.; Wang, L.; Schubert, M.-L.; Hoffmann, J.-M.; Wang, S.; Neuber, B.; Hückelhoven-Krauss, A.; Gern, U.; Schmitt, A.; Müller-Tidow, C.; Dreger, P.; Mokhir, A.; Schmitt, M.; Sellner, L.* Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies. Int. J. Mol. Sci., 2019, 20(10), 10.3390/ijms20102469.
  9. Karawacka, W.; Janko, C.; Unterweger, H.; Mühlberger, M.; Taccardi, N.; Mokhir, A.; Jira, W.; Peukert, W.; Boccaccini, A.; Kolot, M.; Alexiou, C.; Tietze, R.* SPIONs functionalized with small peptides for binding of lipopolysaccharide, a pathophysiologically relevant microbial product. Colloids & Surfaces B: Biointerfaces, 2019, 174 (Feb. 1), 95-102.

2018

  1. Reshetnikov, V.; Daum, S.; Janko, C.; Karawacka, W.; Tietze, R.; Alexiou, C.; Paryzhak, S.; Dumych, T.; Bilyy, R.; Tripal, P.; Schmid, B.; Palmisano, R.; Mokhir, A.* ROS-responsive N-alkylaminoferrocenes for cancer cell specific targeting of mitochondria. Angew. Chem. Int. Ed., 2018, 57, 11943-11946.
  2. Reshetnikov, V.; Hahn, J.; Maueröder, C.; Czegley, C.; Munoz, L. E.; Herrmann, M.; Hoffmann, M. H.;* Mokhir, A.* Chemical tools for targeted amplification of reactive oxygen species in neutrophils. Frontiers in Immunology, 2018, Aug. 13: 9, 1827; doi: 10.3389/fimmu.2018.01827.
  3. Reshetnikov, V.; Arkhypov, A.; Julakanti, P. R., Mokhir, A.* A cancer specific oxaliplatin-releasing Pt(IV)-prodrug. Dalton Trans., 2018, 47, 6679-6682.
  4. Daum, S.; Babiy, S.; Konovalova, H.; Hofer, W.; Shtemenko, A.; Shtemenko, N.; Janko, C.; Alexiou, C.; Mokhir, A.* Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution. J. Inorg. Biochem., 2018, 178, 9-17.
  5. Dietrich, S;* Oleś, M;* Lu, J.; Sellner, L.; Anders, S.; Velten, B.; Wu, B.; Hüllein, J.; da Silva Liberio, M.; Walther, T.; Wagner, L.; Rabe, S.; Ghidelli-Disse, S.; Bantscheff, M.; Oleś, A. K.; Slabicki, M.; Mock, A.; Oakes, C.; Wang, S.; Oppermann, S.; Lukas, M.; Kim, V.; Sill, M.; Benner, A.; Jauch, A.; Sutton, L. A.; Young, E.; Rosenquist, R.; Liu, X.; Jethwa, A.; Lee, K. S.; Lewis, J.; Putzker, K.; Lutz, C.; Rossi, D.; Mokhir, A.; Oellerich, T.; Zirlik, K.; Herling, M.; Nguyen-Khac, F.; Plass, C.; Andersson, E.; Mustjoki, S.; von Kalle, C.; Ho, A. D.; Hensel, M.; Dürig, J.; Ringshausen, I.; Zapatka, M.; Huber, W.;* Zenz, T.* Drug perturbation based stratification of blood cancer. J. Clinical Investigation, 2018, 128(1), 427–445.
  6. Yan. Z. Voloshin,* Valentin V. Novikov, Yulia V. Nelyubina, Alexander S. Belov, Dmitrii M. Roitershtein, Anton Savitsky, Andriy Mokhir, Jörg Sutter, Matthias Miehlich, Karsten Meyer,* Synthesis and characterization of an Fe(I) cage complex with high stability towards strong H-acids. Chem. Comm., 2018, 54, 3436-3439.
  7. Toms, J.; Reshetnikov, V.; Maschauer, S.; Mokhir, A.; Prante, O.* Radiosynthesis of an 18F-fluoroglycosylated aminoferrocene for in-vivo imaging of reactive oxygen species activity by PET. J. Labelled Compounds & Radiopharmaceuticals, 2018, 61(14), 1081-1088.

2017

  1. Daum, S.; Reshetnikov, V.; Sisa, M.; Dumych, T.; Lootsik, M. D.; Bilyy, R.; Bila, E.; Janko, C.; Alexiou, C.; Herrmann, M.; Sellner, L.; Mokhir, A.* Lysosome-targeting amplifiers of reactive oxygen species as anticancer prodrugs. Angew. Chem. Int. Ed., 2017, 56(49), 15545-15549.
  2. Reshetnikov, V.; Daum, S.; Mokhir, A.* Cancer specific, intracellular, reductive activation of anticancer Pt(IV)-prodrugs. Chem. Eur. J., 2017, 23(24), 5678-5681.
  3. Kovalska, V.*; Kuperman, M.; Kryvorotenko, D.; Kinski, E.; Schikora, M.; Varzatskii, O.; Janko, C.; Alexiou, C.; Yarmoluk, S.; Mokhir, A.* [1,10]Phenanthroline based cyanine dyes as fluorescent probes for ribonucleic acids in live cells. Methods and Applications in Fluorescence, 2017, 5(4), 045002, DOI: 10.1088/2050-6120/aa8510.
  4. Chekhun, V. F.;* Lukianova, N. Y.; Borikun, T. V.; Zadvornyi, T. V.; Mokhir, A. Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics., Exp. Oncology, 2017, 39, 1, 25-29.
  5. Kovbasyuk, L.; Mokhir, A.* Toxicity studies and biomedical applications of graphene oxide. Book chapter (Graphene Oxide: Fundamentals and Applications, John Wiley  Sons Ltd, A. Dimiev, S. Eigler, Eds.), 2017.

2016

  1. Pieper, H.; Chercheja, S.; Eigler, S.; Halbig, C.; Filipovic, M. R.; Mokhir, A.* Endoperoxides revealed as origin of toxicity of graphene oxide. Angew. Chem. Int. Ed 2016, 55(1), 405-407.
  2. Pieper, H.; Halbig, C. E.; Kovbasyuk, L.; M. R. Filipovic, Eigler, S.;* Mokhir, A.* Oxo-functionalized graphene as cell membrane carrier of nucleic acids probes controlled by aging. Chem. Eur. J., 2016, 22(43), 15389-15395.
  3. Meyer, A.; Schikora, M.; Starkuvienne, V.; Mokhir, A.* Red light activated „caged“ reagents for micro RNA research. Photochem. Photobiol. Sci., 2016, 15(9), 1120-1123.
  4. Schikora, M.; Mokhir, A.* Cu(II)-complexes as quenchers of photocatalytic activity of visible light-absorbing photosensitizers: an application in detection of nucleic acids. Inorg. Chim. Acta, 2016, (special issue on „Metal-nucleic acid interactions – state of the art“). 452, 118-124.
  5. Kinski, E.; Marzenell, P.; Hofer, W.; Hagen, H.; Raskatov J. A.; Knaup, K. X.; Zolnhofer, E. M.; Meyer, K.; Mokhir, A.* 4-Azidobenzyl ferrocenylcarbamate as an anticancer prodrug activated at reductive conditions. J. Inorg. Biochem. 2016, 160, 218-224 (special issue: Metallodrugs/COST action).
  6. Blechinger, J.; Varzackii, O.; Kovalska, V.; Zelinskii, G. E.; Voloshin, Y. Z.; Mokhir, A.* Cytotoxicity of electrophilic iron(II)-clathrochelates in human promyelocytic leukemia cell line. Bioorg. Med. Chem. Lett. 2016, 26(2), 626-629.
  7. Beierlein, F. R.;* Palomo, M. P.; Sharapa, D. I.; Zozulia, O.; Mokhir, A.; Clark, T. DNA-dye-conjugates: conformation and spectra of fluorescence probes. PLOS ONE, 2016, 11(7), e0160229.

2015

  1. Meyer, A.; Schikora, M.; Mokhir, A.* Red light controlled polymerase chain reaction. Chem. Comm. (2015), 51, 13324-13326.
  2. Daum, S.; Chekhun, V.; Todor, I.; Lukianova, N.; Shvets, Y.; Sellner, L.; Putzker, K.; Lewis, J.; Zenz, T.; Graaf, I.; Groothuis, G.; Casini, A.; Zozulia, O.; Hampel, F.; Mokhir, A.* Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity. J. Med. Chem. (2015), 58(4), 2015-2024.
  3. Schikora, M.; Reznikov, A.; Chaykovskaya, L.; Sachinska, O.; Polyakova, L.; Mokhir, A.* Activity of aminoferrocene-based prodrugs against prostate cancer. Bioorg. Med. Chem. Lett. (2015), 25(17), 3447-3450.
  4. Mokhir, A.* Chemical reactions controlled by nucleic acids. Book chapter (DNA in Supramolecular Chemistry and Nanotechnology, John Wiley & Sons, Ltd, Eds. E. Stulz and G. H. Clever). 2015. ISBN: 978-1-118-69686-6.
  5. Chekhun, V.F.; Mokhir, A.; Daum, S.; Todor, I.N.*; Lukianova, N.Yu.; Shvets, Yu.V.; Burlaka, A.P. Pharmacological effect of aminoferrocene in mice with L1210 leukemia. Exp. Oncology. (2015), 37(2), 120-125.

2014

  1. Meyer, A.; Mokhir, A.* RNA interference controlled by light of variable wavelength. Angew. Chem. Int. Ed., (2014), 53(47), 12840-12843.
  2. Marzenell, P.; Hagen, H.; Blechinger, J.; Erfle, H.; Mokhir, A.* Terminally modified, short phosphorothioate oligonucleotides as inhibitors of gene expression in cells. Bioorg. Med. Chem. Lett., (2014), 24(19), 4694-4698.
  3. Kovalska, V. B.;* Losytskyy, M. Yu.; Varzatskii, O. A.; Cherepanov, V. V.; Voloshin, Y. Z.; Mokhir, A.; Yarmoluk, S. M.; Volkov, S. V. Study of anti-fibrinogenic activity of iron(II) clathrochelates, Bioorg. Med. Chem., (2014), 22(6), 1883-1888.
  4. Schikora, M., Dutta, S.; Mokhir, A.* Nucleic acid – specific photoactivation of oligodeoxyribonucleotides labeled with deuterated dihydro-N,N,N‘,N‘-tetramethylrhodamine using green light, Histochem. Cell Biol., (2014), 142(1), 103-111.

2013

  1. König, S.; Mokhir, A.* „Caged“ peptide nucleic acids activated by red light in a singlet oxygen-mediated process, Bioorg. Med. Chem. Lett., (2013), 23(24), 6544-6548.
  2. Marzenell, P.; Hagen, H.; Sellner, L.; Zenz, T.; Grinyte, R.; Pavlov, V.; Daum, S.; Mokhir, A.* Aminoferrocene-based prodrugs and their effects on human normal and cancer as well as bacterial cells, J. Med. Chem., (2013), 56(17), 6935-6944.
  3. Dutta, S.; Fülöp, A.; Mokhir, A.* A fluorogenic, catalytic, photochemical reaction for amplified detection of nucleic acids, Bioconjugate Chemistry, (2013), 24(9), 1533-1542.
  4. Degtyarenko, A. S.; Rusanov, E. B.; Bauza, A.; Frontera, A.; Krautscheid, H.; Chernega, A. N.; Mokhir, A.; Domasevitch, K. V.*, Self-assembly cavitand precisely recognizing hexafluorosilicate: a concerted action of two coordination and twelve CH…F bonds, Chem. Comm., (2013), 49(79), 9018-9020.
  5. Dolganov, A. V.; Belov, A. S.; Novikov, V. V.; Vologzhanina, A. V.; Mokhir, A.; Bubnov, Y. N.; Voloshin, Y. Z.* Iron vs. cobalt clathrochelate electrocatalysis of HER: the first example on a cage iron complex, Dalton Trans, (2013), 42, 4373-4376.
  6. Blechinger, J.; Pieper, H.; Marzenell, P.; Kovbasyuk, L.; Serva, A.; Starkuviene, V.; Erfle, H.; Mokhir, A. * Short, terminally modified 2′-OMe RNAs as inhibitors of microRNA, Chem. Comm., (2013), 49, 7397-7399.

2012

  1. Dutta, S.; Flottmann, B.; Heilemann, M.; Mokhir, A.* Hybridization and reaction-based, fluorogenic nucleic acid probes, Chem. Comm. (2012), 47, 9664-9666.
  2. Hagen, H.; Marzenell, P.; Jentzsch, E.; Wenz, F.; Veldwijk, M. R.; Mokhir, A.* Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species, J. Med. Chem., (2012), 55(2), 924-934.
  3. Krämer, R.* und Mokhir, A. Metal Complex Derivatives of Peptide Nucleic Acids in „Interplay between Metal Ions and Nucleic Acids“, Vol. 10 of ‚Metal Ions in Life Sciences‘, A. Sigel, H. Sigel, R. K. O. Sigel, Eds.; Springer Science + Business Media B.V., Dordrecht, 2012, chapter 12, pp. 319-340.

2011

  1. Arian, D.; Kovbasyuk, L.; Mokhir, A.* Control of the Photocatalytic Activity of Bimetallic Complexes of Pyropheophorbide-a by Nucleic Acids, Inorg. Chem., (2011), 50(23), 12010-12017.
  2. Arian, D.; Kovbasyuk, L.; Mokhir, A.* 1,9-Di(alkoxy)anthracene as a Singlet Oxygen-Sensitive Linker, J. Am. Chem. Soc. (2011), 133(11), 3972-3980.
  3. Dutta, S.; Mokhir, A.* An autocatalytic chromogenic and fluorogenic photochemical reaction controlled by nucleic acids, Chem. Comm. (2011), 47(4), 1243-1245.

2010

  1. Helmig, S.; Rotaru, A.; Arian, D.; Kovbasyuk, L.; Arnbjerg, J.; Ogilby, P.R.; Kjems, J.; Mokhir, A., Besenbacher, F.; Gothelf, K.V.* Single Molecule AFM Studies of Photosensitized Singlet Oxygen Behavior on a DNA Origami Template, ACS Nano. (2010), 4(12), 7475-7480.
  2. Rotaru, A.; Dutta, S. Jentzsch, E.; Gothelf, K. V.; Mokhir, A.* Selective dsDNA-templated formation of copper nanoparticles in solution. Angew. Chem. (2010), 122(33), 5799-5802.
  3. Fülöp, A.; Peng, X.; Greenberg, M.M.; Mokhir, A.* A nucleic acid directed, red light- induced chemical reaction. Chem. Comm. (2010), 46, 5659-5661.
  4. Voigt, N.V.; Tørring, T.; Rotaru, A.; Jacobsen, M.F.; Ravnsbæk, J.B.; Subramani, R.; Mamdouh, W.; Kjems, J.; Mokhir, A.; Besenbacher, F.; Gothelf, K.V.* Single Molecule Chemical Reactions on DNA Origami. Nature Nanotech. (2010), 5, 200-203.
  5. Arian, D.; Cló, E.; Gothelf, K.V.; Mokhir, A.* A nucleic acid dependent chemical photocatalysis in live cells. Chem., Eur. J. (2010), 16(1), 288-295.